Evidence map›Paper›PMID 31590384›Full record

ArticleInternational journal of molecular sciences2019

KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction.

Francesco Vieceli Dalla Sega, Raffaella Mastrocola, Giorgio Aquila, Francesca Fortini, Claudia Fornelli, Alessia Zotta, Alessia S Cento, Andrea Perrelli, Enrica Boda, Antonio Pannuti and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. mPR-Specific Actions Influence Maintenance of the Blood-Brain Barrier (BBB).International journal of molecular sciences · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Vitamin D Deficiency and the Risk of Cerebrovascular Disease.Antioxidants (Basel, Switzerland) · 2020
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Francesco Vieceli Dalla SegaMaria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. vclfnc@unife.it.
Raffaella MastrocolaDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. raffaella.mastrocola@unito.it.ORCID 0000-0002-0104-6129
Giorgio AquilaDepartment of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy. qlagrg@unife.it.ORCID 0000-0002-3936-8895
Francesca FortiniMaria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. frtfnc@unife.it.
Claudia FornelliDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. claudia.fornelli@unito.it.
Alessia ZottaDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. alessia.zotta@unito.it.
Alessia S CentoDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. alessiasofia.cento@unito.it.
Andrea PerrelliDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. andrea.perrelli@unito.it.ORCID 0000-0001-8512-6080
Enrica BodaCCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. enrica.boda@unito.it.ORCID 0000-0002-1006-2577
Antonio PannutiUniversity of Hawaii Cancer Center, University of Hawaii, Honolulu, HI 96822, USA. apannut@mac.com.
Saverio MarchiCCM Italia Research Network, National Coordination Center at the Department of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. s.marchi@univpm.it.
Paolo PintonMaria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. pnp@unife.it.
Roberto FerrariMaria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. fri@unife.it.
Paola RizzoMaria Cecilia Hospital, GVM Care & Research, 48033 Cotignola (RA), Italy. francesco.retta@unito.it.
Saverio Francesco RettaDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano (TO), Italy. rzzpla@unife.it.ORCID 0000-0001-9761-2959
University of Turin · ITMaria Cecilia Hospital · ITUniversity of Ferrara · ITMarche Polytechnic University · ITNeuroscience Institute · ITUniversity of Hawaiʻi at Mānoa · US

Funding

Telethon GGP15219/Coordinator
6 · The paper itself

Abstract

Loss-of-function mutations of the gene encoding Krev interaction trapped protein 1 (KRIT1) are associated with the pathogenesis of Cerebral Cavernous Malformation (CCM), a major cerebrovascular disease characterized by abnormally enlarged and leaky capillaries and affecting 0.5% of the human population. However, growing evidence demonstrates that KRIT1 is implicated in the modulation of major redox-sensitive signaling pathways and mechanisms involved in adaptive responses to oxidative stress and inflammation, suggesting that its loss-of-function mutations may have pathological effects not limited to CCM disease. The aim of this study was to address whether KRIT1 loss-of-function predisposes to the development of pathological conditions associated with enhanced endothelial cell susceptibility to oxidative stress and inflammation, such as arterial endothelial dysfunction (ED) and atherosclerosis. Silencing of KRIT1 in human aortic endothelial cells (HAECs), coronary artery endothelial cells (HCAECs), and umbilical vein endothelial cells (HUVECs) resulted in increased expression of endothelial proinflammatory adhesion molecules vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) and in enhanced susceptibility to tumor necrosis factor alpha (TNF-α)-induced apoptosis. These effects were associated with a downregulation of Notch1 activation that could be rescued by antioxidant treatment, suggesting that they are consequent to altered intracellular redox homeostasis induced by KRIT1 loss-of-function. Furthermore, analysis of the aorta of heterozygous

Indexed as

Loss of Function MutationAnimalsAortaApoptosisAtherosclerosisEndothelium, VascularHumansHuman Umbilical Vein Endothelial CellsIntercellular Adhesion Molecule-1KRIT1 ProteinLipid MetabolismMiceMice, Inbred C57BLOxidative StressReceptor, Notch1Tumor Necrosis Factor-alphaIntercellular Adhesion Molecule-1KRIT1 ProteinKrit1 protein, mouseReceptor, Notch1Tumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1atherosclerosiscerebral cavernous malformation (CCM)endothelial dysfunction (ED)ICAM-1KRIT1Notch1notch signalingoxidative stressROSVCAM-1

Identifiers

PMID31590384
PMCPMC6801783
OpenAlexW2978821893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.